Panagora Asset Management’s Novo Nordisk NVO Stock Holding History

Panagora Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	+36,140	New	+$1.55M	0.01%	660
2017 Q1	–	Sell	-12,130	Closed	-$217K	–	2425
2016 Q4	$217K	Hold	12,130	–	–	﹤0.01%	1730
2016 Q3	$252K	Buy	+12,130	New	+$301K	﹤0.01%	1684
2014 Q3	–	Sell	-1,584	Closed	-$37K	–	2331
2014 Q2	$37K	Buy	+1,584	New	+$35K	﹤0.01%	2153

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Panagora Asset Management's NVO Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 36,140 shares worth $1.73M. The stake represents 0.01% of the portfolio and ranks #660 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in NVO as recently as Q4 2016.

Panagora Asset Management first reported a position in NVO in Q2 2014 and has held it in 4 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Panagora Asset Management held 36,140 shares of Novo Nordisk worth $1.73M as of Q2 2026.
Novo Nordisk was a new Panagora Asset Management position in Q2 2026.
Novo Nordisk made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #660 holding.
Panagora Asset Management first reported a position in Novo Nordisk in Q2 2014 and has held it in 4 quarters since.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.